![](/img/cover-not-exists.png)
94O Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data
Gao, B, Goh, J, Markman, B, Voskoboynik, M, Gan, H K, Coward, J, Palmieri, D, So, J, Meniawy, T, Chen, C, Xiang, X, Qiu, J, Xu, Y, Yang, L, Millward, MVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz451.003
Date:
December, 2019
File:
PDF, 90 KB
english, 2019